期刊文献+

急性缺血性脑卒中患者阿司匹林抵抗的风险因素分析 被引量:7

Analysis of risk factors of aspirin resistance in patients with acute ischemic stroke
在线阅读 下载PDF
导出
摘要 目的通过光学比浊法(LTA)检测血小板功能评价阿司匹林疗效,并对影响阿司匹林疗效的可能风险因素进行评估。方法收集2018年11月至2020年1月于北京天坛医院住院治疗的急性缺血性脑卒中患者186例,根据血小板聚焦率结果将其划分为阿司匹林抵抗组31例,阿司匹林非抵抗组155例,比较两组患者的临床资料及实验室指标,并采用Logistic回归进行阿司匹林抵抗的风险因素分析。结果与阿司匹林非抵抗组比较,阿司匹林抵抗组患者红细胞分布宽度(RDW)参数RDW-SD及RDW-CV偏大,差异有统计学意义(P<0.05),既往有吸烟史及脑卒中病史的比例更高(P<0.05)。Logistic回归分析显示吸烟史(OR=4.918,95%CI:1.657~14.590,P=0.004)和RDW-CV(OR=1.397,95%CI:1.070~1.823,P=0.014)为阿司匹林抵抗的独立风险因素。结论吸烟史和高水平RDW-CV为阿司匹林抵抗的独立风险因素,二者有助于早期识别阿司匹林抵抗高风险人群。 Objective To evaluate the efficacy of aspirin by detecting platelet function by optical turbidimetry(LTA),and to evaluate the possible risk factors leading to the efficacy of aspirin.Methods A total of 186 patients with acute ischemic stroke who were hospitalized in Beijing Tiantan Hospital from November 2018 to January 2020 were collected.According to the platelet aggregation rate results,they were divided into aspirin-resistant group(n=31)and aspirin-non-resistant group(n=155).The clinical data and laboratory indicators of the two groups of patients were analyzed and Logistic regression to analyze the risk factors of aspirin resistance was used.Results Compared with the aspirin non-resistant group,the red blood cell distribution width(RDW)parameters RDW-SD and RDW-CV of patients in the aspirin resistant group were larger,and the difference was statistically significant(P<0.05).The proportion of those with a history of smoking and stroke was higher(P<0.05).Logistic regression analysis showed that smoking history(OR=4.918,95%CI:1.657-14.590,P=0.004)and RDW-CV(OR=1.397,95%CI:1.070-1.823,P=0.014)were independent risk factors for aspirin resistance.Conclusion Smoking history and high levels of RDW-CV constitute independent risk factors for aspirin resistance,and both help to identify people at high risk of aspirin resistance early.
作者 李虓 张丽敏 孙越红 王丹 史从宁 张国军 LI Xiao;ZHANG Limin;SUN Yuehong;WANG Dan;SHI Congning;ZHANG Guojun(Department of Clinical Laboratory,Beijing Tiantan Hospital Affiliated to Capital Medical University,Beijing 100070,China;Beijing Engineering Research Center of Immunological Reagents Clinical Research,Beijing 100070,China)
出处 《国际检验医学杂志》 CAS 2020年第17期2100-2103,2111,共5页 International Journal of Laboratory Medicine
基金 北京天坛医院院青年科学基金(2016-YQN-09) 首都医科大学科研培育基金(PYZ2017067)。
关键词 光学比浊法 红细胞分布宽度 缺血性脑卒中 阿司匹林抵抗 optical turbidimetry red blood cell distribution width ischemic stroke aspirin resistance
作者简介 李虓,男,主管技师,主要从事临床基础检验;通信作者:张国军,E-mail:tiantanzgj@163.com。
  • 相关文献

参考文献8

二级参考文献71

  • 1Xian-Feng Liu,Jian Cao,Li Fan,Lin Liu,Jian Li,Guo-Liang Hu,Yi-Xin Hu,Xiao-Li Li.Prevalence of and risk factors for aspirin resistance in elderly patients with coronary artery disease[J].Journal of Geriatric Cardiology,2013,10(1):21-27. 被引量:11
  • 2夏煜,倪秀石.颈动脉粥样硬化与脑梗死相关性的超声研究[J].国际脑血管病杂志,2006,14(3):205-209. 被引量:20
  • 3Mehta SR, YusufS, Peters R J, Bertrand ME, Lewis BS, Natarajan MK, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE study. Lancet 2001,358:527-33.
  • 4Steinhubl SR, Berger PB, Mann JT 3rd, Fry ET, DeLago A, Wilmer C, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: A randomized controlled trial. JAMA 2002,288:2411-20.
  • 5Matetzky S, Shenkman B, Guetta V, Shechter M, Beinart R, Goldenberg 1, et al. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation 2004,109:3171-5.
  • 6Price M J, Endemann S, Gollapudi RR, Valencia R, Stinis CT, Levisay JE et al. Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation. Eur Heart J 2008,29:992-1000.
  • 7Bonello L, Camoin-Jau L, Arques S, Boyer C, Panagides D, Wittenberg O, et al. Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: A multicenter randomized prospective study. J Am Coil Cardiol 2008,51:1404-11.
  • 8Bliden KP, DiChiara J, Tantry US, Bassi AK, Chaganti SK, Gurbel PA. Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary inter'ention: Is the current antiplatelet therapy adequate'? J Am Coil Cardiol 2007,49:657-66.
  • 9Gurbel PA, Becker RC, Mann KG, Steinhubl SR, Michelson AD. Platelet function monitoring in patients with coronary artery disease. J Am Coil Cardiol 2007,50:1822-34.
  • 10Bonello L, Tantry US, Marcucci R, Blindt R, Angiolillo DJ, Becker R, et al. Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. J Am Coil Cardiol 2010,56:919-33.

共引文献121

同被引文献80

引证文献7

二级引证文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部